12:00 AM
 | 
Mar 03, 2014
 |  BC Week In Review  |  Clinical News  |  Regulatory

GA-map IBS Dysbiosis Test regulatory update

Genetic Analysis said its GA-map IBS Dysbiosis Test received CE Mark approval to analyze dysbiosis (imbalances in gut microbiota) in patients with irritable bowel syndrome (IBS) and...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >